Position in AXGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,394,793
+$3,640,197 QoQ
Shares Held
95,146
+133.3% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#79
of 253 holders
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $190,225,782 across 12 Medical Devices names. AXGN ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
112,069 | $35,283,803 | |
| 2 | MDT |
Medtronic plc
|
425,833 | $33,312,915 | |
| 3 | PEN |
Penumbra Inc
|
91,863 | $29,005,742 | |
| 4 | BSX |
Boston Scientific Corp
|
677,114 | $28,899,225 | |
| 5 | ABT |
Abbott Laboratories
|
243,068 | $22,055,990 | |
| 6 | EW |
Edwards Lifesciences Corp
|
160,091 | $14,481,831 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
106,017 | $6,786,148 | |
| 8 | DXCM |
Dexcom Inc
|
95,248 | $6,414,952 |
All Filings in AXGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,394,793 | 95,146 | Shares | Other | 2026-07-31 | |
| 2025-03-31 | $754,596 | 40,789 | Shares | Other | 2025-04-29 | |
| 2024-12-31 | $522,827 | 31,725 | Shares | Other | 2025-01-24 | |
| 2021-03-31 | $2,949,855 | 145,600 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,316,329 | 73,538 | Shares | Other | 2021-01-27 | |
| No filing history on record for this holder in this stock. | ||||||